Advertisement

Topics

BioMolecular Therapeutics, Inc. Company Profile

14:47 EST 3rd December 2016 | BioPortfolio

An early-stage biopharmaceutical company, BMT is pioneering the development of novel RNAi therapeutics to prevent and treat age-related macular degeneration based on the company's proprietary technology, asymmetric shorter-duplex siRNA (asiRNA). This novel RNAi technology significantly reduces deleterious side effects triggered by conventional siRNA, especially, the stimulation of the innate immune system, which makes it feasible to use asiRNA for the treatment of age-related macular degeneration, a disease to which RNAi therapeutics could not be developed using conventional siRNAs. Other potential applications for BMT's technology include therapeutics targeting infectious disease, such as herpes simplex virus (HSV), and cancer. A privately held company based in Suwon, South Korea, BMT was established in 2010.


News Articles [1915 Associated News Articles listed on BioPortfolio]

#jobs #lifescience Pathobiology: Assistant Professor of Biomolecular Pharmaceutical Pathobiology

// Starting salary will be commensurate with professional and academic credentials and experience.: Pathobiology: Assistant Professor of Biomolecular Pharmaceutical Pathobiology at Auburn University C...

10,000 windows onto biomolecular information processing

(University of Tokyo) A Franco-Japanese research group at the University of Tokyo has developed a new 'brute force' technique to test thousands of biochemical reactions at once and quickly home in on ...

Biomolecular systems investigated at the highest resolution at the University of Leeds

Bruker’s Nano Surfaces Division reports on the groundbreaking use of a Dimension FastScan Bio™ AFM system at the University of Leeds, UK, to investigate biological and biomolecular systems at the ...

PX'Therapeutics und RELIEF THERAPEUTICS Holding AG kündigen strategischen Kooperationsvertrag für rekombinante Produktion von Atexakin Alfa an

PX'Therapeutics, Tochtergesellschaft des Aguettant Konzerns, ein Unternehmen, das sich auf die kundenspezifische Entwicklung rekombinanter Proteine konzentriert, und die RELIEF THERAPEUTICS Holdin...

Domain Therapeutics sets up Mavalon Therapeutics, with financial backing from Medicxi

French drug discovery company Domain Therapeutics today announced the creation of Mavalon Therapeutics,…

Research Reports Coverage on Biotech Stocks -- Celldex Therapeutics, Amicus Therapeutics, ...

http://stock-callers.com/registration Celldex Therapeutics  On Thursday, shares in Hampton, New Jerseyheadquartered Celldex Therapeutics Inc. recorded a trading volume of 3.36 million shares, whi...

Seres Therapeutics, Emulate collaborate to support development of novel microbiome therapeutics

Seres Therapeutics, a microbiome therapeutics platform company, and Emulate, a private firm commercializing the Organs-on-Chips technology, announced a new collaboration.

Relief Therapeutics kündigt strategische Allianz mit PX'Therapeutics an

Genf/Grenoble (awp) - Das Biotechunternehmen Relief Therapeutics kündigt eine strategische Zusammenarbeit mit PX'Therapeutics an. Gemeinsam werden die beiden Unternehmen an der Produktion von Atexa.....

Drugs and Medications [0 Results]

None

PubMed Articles [722 Associated PubMed Articles listed on BioPortfolio]

Portable, On-Demand Biomolecular Manufacturing.

Synthetic biology uses living cells as molecular foundries for the biosynthesis of drugs, therapeutic proteins, and other commodities. However, the need for specialized equipment and refrigeration for...

Injectable biomaterials: a perspective on the next wave of injectable therapeutics.

We are experiencing a new wave of injectable therapeutics (namely/injectable biomaterials) to complement injectable drugs and injectable biologics, and to serve as the basis for injectable combinatori...

Response #2 to Immediate Intraocular Pressure Tendency Following Intravitreal Delivery of Dexamethasone Implant; Alagöz et al. J. Ocul. Pharmacol. Ther. 32:44-49, 2016.

Comparison of Self-Reported and Objective Adherence to Antiglaucoma Medications.

Pigmentation and Macular Degeneration: Is There a Role for GPR143?

Clinical Trials [19 Associated Clinical Trials listed on BioPortfolio]

Beat AML Core Study

In this study, DNA sequencing, computational biology modeling, and ex vivo drug sensitivity assays will be utilized to define clinically relevant gene mutations and identify potential ther...

Localized Therapeutics for the Treatment of Gastrointestinal Disorders II

The purpose of this study is to investigate a novel thermosensitive topical gel formulation for the treatment of inflammatory bowel disease (IBD), specifically ulcerative colitis.

Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics

The emergence of oral delivery in cancer therapeutics is expected to result in an increased need for better coordination between all treatment stakeholders, mainly to ensure adequate treat...

Biomolecular Messages Associated With the Differentiation of Human Induced Pluripotent Stem Cells to Skeletal Muscle Progenitor Cells

Female urinary incontinence and pelvic organ prolapse are common diseases especially in aged women that frequently cause urogenital infection, voiding difficulty, urinary retention, pelvic...

MIR200C Socket Study, Pilot Clinical Trial

To evaluate the efficacy of locally delivering plasmid DNAs encoding MIR200c in the promotion of osteogenesis and modulation of the inflammatory response on the basis of different clinical...

Companies [21 Associated Companies listed on BioPortfolio]

Association of Biomolecular Resource Facilities

The Association of Biomolecular Resource Facilities is an international society dedicated to advancing core and research biotechnology laboratories through research, communication, and education.

Centre for Molecular and Biomolecular Informatics

Welcome at the CMBI, which is short for Centre for Molecular and Biomolecular Informatics. The centre performs research and education, and provides services in bioinformatics and cheminformatics.

Aquasome

A platform nanoparticulate technology for biomolecular delivery in a broad range of industrial, personal use, and biomedical applications.

Society for Biomolecular Sciences

The Society for Biomolecular Sciences' mission is to advance the science of drug discovery and related disciplines by providing a forum for education and information exchange among professionals aroun...

BiOptix

BiOptix offers an affordable and powerful solution for drug discovery scientists that require label-free real-time detection of biomolecular interactions. The unique SPR-enhanced ...

More Information about "BioMolecular Therapeutics, Inc." on BioPortfolio

We have published hundreds of BioMolecular Therapeutics, Inc. news stories on BioPortfolio along with dozens of BioMolecular Therapeutics, Inc. Clinical Trials and PubMed Articles about BioMolecular Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioMolecular Therapeutics, Inc. Companies in our database. You can also find out about relevant BioMolecular Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record